Ophthalmology Groups and AMA Urge CMS to Clarify Modifier -25 Use for Intravitreal Injections, Pause Audits

Here’s the latest in our push for CMS to fix conflicting coding guidance that could limit Medicare patients' access to critical retinal treatments.